TABLE 2. Summary of Treatment-Emergent Adverse Events.
Category | 30-min IV Infusion HTX-019 130 mg (N = 147) |
---|---|
Patients with ≥1 TEAE, n (%) | 9 (6) |
Total number of TEAEs | 14 |
HTX-019-related TEAEs | 0 |
TEAE, n (%) | |
Feeling hot | 4 (3) |
Dizziness | 2 (1) |
Pruritusa | 2 (1) |
Nausea | 1 (1) |
Shortness of breath | 1 (1) |
Feeling weird | 1 (1) |
Chest tightness | 1 (1) |
Lower back pain | 1 (1) |
Erythema | 1 (1) |
Abbreviations: IV, intravenous; min, minute; TEAE treatment-emergent adverse event.
aPruritus includes itch and itchy scalp.